AKR1B10 and metastatic malignant neoplasm in the lymph nodes: By contrast, patients who underwent neoadjuvant chemotherapy showed that high AKR1B10 expression was associated with lymph node metastasis and a poorer prognosis, along with a weak response to neoadjuvant chemotherapy [79].